The U.S. Hematology Oncology Market was valued at USD 3.39 Billion in 2024 and is expected to reach USD 8.86 Billion by 2032, growing at a CAGR of 9.2% (2025-2032).
The Global Topoisomerase-I Payload ADC Drugs Market was valued at USD 4.88 Billion in 2025 and is expected to reach USD 16.33 Billion by 2033, growing at a CAGR of 16.3% (2026-2033).
The Global Interventional Oncology Market was valued at USD 2.63 Billion in 2024 and is expected to reach USD 4.48 Billion by 2032, growing at a CAGR of 6.89% (2025-2032).
The Global Personalized Cancer Vaccines Market was valued at USD 234,790.00 Million in 2022 and is expected to reach USD 371,404.60 Million by 2030, growing at a CAGR of 5.9% (2023-2030).